Tumor Necrosis Factor Blocking Therapy and Congestive Heart Failure in Patients with Inflammatory Rheumatic Disorders: A Systematic Review

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|22|16|1892-1902

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.22, Iss.16, 2015-05, pp. : 1892-1902

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Editorial: Tumour Necrosis Factor As a Potential Target for the Treatment of Congestive Heart Failure

By Visioli F.  

Pharmacological Research, Vol. 40, Iss. 2, 1999-08 ,pp. : 91-91

Academic Press

Access to resources Recommend Favorite

Anti Tumor Necrosis Factor-a Monoclonal Antibody (Infliximab) Therapy in Patients with Inflammatory Bowel Disease (IBD): Applications and Side Effects

By  

Drug Design Reviews - Online, Vol. 1, Iss. 2, 2004-01 ,pp. : 111-117

Bentham Science Publishers

Access to resources Recommend Favorite

A Review of Quality-of-Life Evaluations in Patients with Congestive Heart Failure

By Berry C.   McMurray J.  

PharmacoEconomics, Vol. 16, Iss. 3, 1999-09 ,pp. : 247-271

Adis International

Access to resources Recommend Favorite

Is There Any Future for Tumor Necrosis Factor Antagonists in Chronic Heart Failure?

By Arthur M. Feldman  

American Journal of Cardiovascular Drugs, Vol. 4, Iss. 1, 2004-01 ,pp. : 11-19

Adis International

Access to resources Recommend Favorite

Intravenous Vasodilator Therapy in Congestive Heart Failure

By Moazemi K.   Chana J.S.   Willard A.M.   Kocheril A.G.  

Drugs & Aging, Vol. 20, Iss. 7, 2003-01 ,pp. : 485-508

Adis International

Access to resources Recommend Favorite